MSE
REGN icon

MUFG Securities EMEA’s Regeneron Pharmaceuticals REGN Stock Holding History

MUFG Securities EMEA’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.69M Sell
9,126
-8,006
-47% -$5.45M 0.06% 196
2026
Q1 		$13.2M Buy
17,132
+13,000
+315% +$9.95M 0.2% 86
2025
Q4 		$3.19M Buy
4,132
+2,182
+112% +$1.48M 0.04% 241
2025
Q3 		$1.1M Buy
1,950
+1,643
+535% +$929K 0.03% 236
2025
Q2 		$161K Buy
+307
New +$171K 0.01% 238
2022
Q4 		– Sell
-135
Closed -$93K – 175
2022
Q3 		$93K Hold
135
– – ﹤0.01% 123
2022
Q2 		$80K Hold
135
– – ﹤0.01% 107
2022
Q1 		$94K Hold
135
– – ﹤0.01% 127
2021
Q4 		$85K Hold
135
– – ﹤0.01% 169
2021
Q3 		$82K Sell
135
-645
-83% -$400K ﹤0.01% 270
2021
Q2 		$436K Sell
780
-2,100
-73% -$1.06M ﹤0.01% 265
2021
Q1 		$1.36M Buy
2,880
+1,700
+144% +$828K 0.01% 289
2020
Q4 		$570K Buy
1,180
+559
+90% +$302K ﹤0.01% 338
2020
Q3 		$348K Buy
+621
New +$377K ﹤0.01% 351
2020
Q2 		– Sell
-1,280
Closed -$625K – 492
2020
Q1 		$625K Sell
1,280
-1,600
-56% -$660K 0.01% 354
2019
Q4 		$1.08M Buy
2,880
+2,004
+229% +$674K 0.01% 428
2019
Q3 		$243K Sell
876
-59,792
-99% -$17.7M ﹤0.01% 314
2019
Q2 		$19M Buy
60,668
+57,872
+2,070% +$19.3M 0.2% 86
2019
Q1 		$1.15M Sell
2,796
-2,690
-49% -$1.11M 0.01% 380
2018
Q4 		$2.05M Sell
5,486
-5,266
-49% -$1.93M 0.02% 251
2018
Q3 		$4.34M Buy
10,752
+1,721
+19% +$655K 0.06% 171
2018
Q2 		$3.12M Buy
9,031
+152
+2% +$47.5K 0.06% 173
2018
Q1 		$3.06M Sell
8,879
-43,739
-83% -$15.2M 0.06% 147
2017
Q4 		$19.8M Buy
52,618
+49,070
+1,383% +$19.9M 0.46% 51
2017
Q3 		$1.59M Buy
3,548
+1,625
+85% +$773K 0.06% 87
2017
Q2 		$944K Sell
1,923
-3,716
-66% -$1.63M 0.04% 63
2017
Q1 		$2.19M Buy
5,639
+3,802
+207% +$1.41M 0.11% 30
2016
Q4 		$674K Buy
1,837
+764
+71% +$291K 0.06% 25
2016
Q3 		$431K Buy
+1,073
New +$430K 0.39% 26

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

MUFG Securities EMEA's REGN Position: Q2 2026 in Review

MUFG Securities EMEA reduced its Regeneron Pharmaceuticals (REGN) stake by 47% in Q2 2026, selling an estimated $5.45M and leaving 9,126 shares worth $5.69M. The position accounts for 0.06% of the portfolio, ranked #196.

MUFG Securities EMEA first reported a position in REGN in Q3 2016 and has held it in 29 quarters since. The position peaked at $19.8M in Q4 2017. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • MUFG Securities EMEA held 9,126 shares of Regeneron Pharmaceuticals worth $5.69M as of Q2 2026.
  • MUFG Securities EMEA sold 8,006 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $5.45M.
  • Regeneron Pharmaceuticals made up 0.06% of MUFG Securities EMEA's portfolio in Q2 2026, its #196 holding.
  • MUFG Securities EMEA first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 29 quarters since.
  • MUFG Securities EMEA's Regeneron Pharmaceuticals position peaked at $19.8M in Q4 2017.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.